"Arthritis, Rheumatoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
Descriptor ID |
D001172
|
MeSH Number(s) |
C05.550.114.154 C05.799.114 C17.300.775.099 C20.111.199
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Arthritis, Rheumatoid".
Below are MeSH descriptors whose meaning is more specific than "Arthritis, Rheumatoid".
This graph shows the total number of publications written about "Arthritis, Rheumatoid" by people in this website by year, and whether "Arthritis, Rheumatoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1997 | 1 | 0 | 1 |
1999 | 2 | 0 | 2 |
2001 | 4 | 1 | 5 |
2002 | 2 | 0 | 2 |
2003 | 0 | 1 | 1 |
2004 | 1 | 0 | 1 |
2005 | 2 | 0 | 2 |
2006 | 4 | 0 | 4 |
2007 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2009 | 3 | 1 | 4 |
2010 | 2 | 0 | 2 |
2011 | 2 | 1 | 3 |
2012 | 2 | 1 | 3 |
2013 | 1 | 1 | 2 |
2014 | 5 | 1 | 6 |
2015 | 7 | 0 | 7 |
2016 | 13 | 0 | 13 |
2017 | 206 | 23 | 229 |
2018 | 212 | 12 | 224 |
2019 | 65 | 10 | 75 |
2020 | 29 | 14 | 43 |
2021 | 21 | 4 | 25 |
To return to the timeline, click here.
Below are the most recent publications written about "Arthritis, Rheumatoid" by people in Profiles.
-
Coping Mechanisms Mitigate Psychological Stress in Patients With Rheumatologic Diseases During the COVID-19 Pandemic. J Clin Rheumatol. 2022 03 01; 28(2):e449-e455.
-
A pharmacist-managed virtual consult service for patients with rheumatologic conditions requiring specialty or infused medications. Am J Health Syst Pharm. 2022 Jan 01; 79(1):e41-e49.
-
Risk of COVID-19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At-Risk Individuals. Arthritis Rheumatol. 2021 12; 73(12):2179-2188.
-
Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis. Rheumatology (Oxford). 2021 10 09; 60(SI):SI3-SI12.
-
RCA2: a scalable supervised clustering algorithm that reduces batch effects in scRNA-seq data. Nucleic Acids Res. 2021 09 07; 49(15):8505-8519.
-
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int. 2021 Nov; 41(11):1925-1931.
-
The role of immunomodulatory medications in the treatment of COVID-19. Curr Opin Rheumatol. 2021 09 01; 33(5):431-445.
-
Effects of the COVID-19 pandemic on psychology and disease activity in patients with ankylosing spondylitis and rheumatoid arthritis Turk J Med Sci. 2021 08 30; 51(4):1631-1639.
-
Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic Turk J Med Sci. 2021 08 30; 51(4):1615-1623.
-
Vitamin D deficiency: concern for rheumatoid arthritis and COVID-19? Mol Cell Biochem. 2021 Dec; 476(12):4351-4362.